OXIS International to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13th
BEVERLY HILLS, Calif., Sept. 9 /PRNewswire-FirstCall/ — OXIS International, Inc., (OTC Bulletin Board: OXIS; Paris: OXI) today announced that Anthony Cataldo, chief executive officer, and Bernie Landes, president, are scheduled to make an investor presentation at the Rodman & Renshaw Annual Global Investment Conference on Monday, September 13, 2010 at 3:15 p.m. Eastern time (12:15 p.m. Pacific time). The conference is being held at The Palace Hotel in New York City.
A live audio webcast of the Company’s presentation at the conference will be available via a link provided at www.oxis.com. An archived replay of the presentation will be available shortly after the presentation time for a period of 90 days.
About OXIS International, Inc.
OXIS International, Inc. develops technologies and products to research, diagnose, treat and prevent diseases of oxidative stress/inflammation associated with damage from free radical and reactive oxygen species (ROS). The company holds the rights to several therapeutic classes of compounds in the area of oxidative stress, and has focused commercialization programs that include SOD (superoxide dismutase), MPO (myeloperoxidase), GPx (glutathione peroxidase), as well as a highly potent antioxidant, Ergothioneine, that may be sold over-the-counter (OTC) as a dietary supplement. Ergothioneine can also be sold to the cosmetics markets as well as the functional food and beverage markets.
SOURCE OXIS International, Inc.